Increase in Prevalence of Fascioliasis to Help Triclabendazole Market Reach US$ 632.1 Mn by 2031, Notes TMR Study

NEW YORK, Feb. 10, 2022 /PRNewswire/ -- The global triclabendazole market is estimated to expand at a CAGR of 4.1% during the forecast period, from 2021 to 2031, note analysts at Transparency Market Research (TMR).

Players in the triclabendazole market are ensuring the availably of their products in veterinary clinics, hospitals, drug stores, and pharmacies. Furthermore, the market is prognosticated to gain the advantage of expansion of the ecommerce industry, notes a research report by TMR.

Due to the COVID-19 pandemic, people from across the globe are increasing focus on strengthening their immunity. As proteins are considered one of the important constituents contributing to good health of an individual, the demand for high-quality milk and protein products has been increased.

Request Brochure of Triclabendazole Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82892

Triclabendazole Market: Key Findings

• Increased number of animals infected with fascioliasis, which is caused due to the consumption of contaminated water plants, including algae or watercress by animals, has resulted in rise in mortality and morbidity rate in these animals. Awareness on the effectiveness of triclabendazole in the treatment of these health issues is boosting their demand, which, in turn, is fueling ample opportunities in the global triclabendazole market.
• Government bodies of several nations such as Western Australia are taking initiatives for the management of infectious diseases such as liver fluke in animals. Moreover, they are availing different treatment options for this disease. This factor is driving business prospects in the triclabendazole market.

Request for Analysis of COVID-19 Impact on Triclabendazole Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82892

Triclabendazole Market: Growth Boosters

• Increase in prevalence of fascioliasis is boosting the need for advanced treatment options for this disease, which, in turn, is creating prominent opportunities in the market
• Rise in efforts of veterinarians to spread awareness among animal owners on available efficient options for the treatment of different health disorders in animals, including liver fluke, is favoring the sales growth of the global triclabendazole market
• Rise in demand for quality meat and protein products is bolstering the market

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82892

Triclabendazole Market: Regional Analysis

• North America is a dominating region in the triclabendazole market, owing to factors such as presence of a large number of livestock and increase in preventive healthcare budgets by regional farmers. Furthermore, the triclabendazole market in North America is prognosticated to gain sizable sales prospects on the back of increase in cases of F. hepatica in cattle and sheep from this region. Moreover, increase in understanding on the effectiveness of triclabendazole for treating the Fasciola hepatica infection is anticipated to create substantial business prospects in the regional market during the forecast period.
• The triclabendazole market in Europe offers prominent growth opportunities due to the presence of many important companies operating in the animal health industry. Furthermore, the market is anticipated to be driven on the back of presence of sizable livestock population and increase in cases of liver fluke in numerous grazing animals in the region.

Buy Triclabendazole Market Research Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=82892&ltype=S

Triclabendazole Market: Competition Landscape

• Companies operating in the global triclabendazole market are strengthening their production capabilities in order to cater to the rising product demand for fascioliasis treatment in animals
• Players are increasing their focus on strengthening their distribution channels
• Several enterprises in the triclabendazole market are investing heavily in R&D projects to advance the efficiency of their products

Triclabendazole Market: Key Players

Some of the key players profiled in the report are:

• RV Lifesciences Limited
• AdvaCare Pharma
• Intas Pharmaceuticals Ltd.
• Grampus Laboratories
• Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd
• Shanghai Tongren Pharmaceutical Co., Ltd.
• Elanco
• Siflon Drugs & Pharmaceuticals Pvt. Ltd.
• Bimeda, Inc.
• Virbac
• Zoetis Health
• Chanelle Pharma

Triclabendazole Market Segmentation

Dosage Form      

• Tablet
• Oral Suspension

Animal Type      

• Cattle
• Sheep
• Goat
• Others

Distribution Channel   

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

Region       

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Cosmetic Lasers Market: Cosmetic procedures are minimally invasive. Laser devices that are used for these procedures rely on the cosmetic issue to be addressed. Growth in the cosmetic industry and increasing awareness about the physical appearance among personnel are expected to drive the cosmetic lasers market.

Surgical Imaging Arms Market: Rise in the number of interventional radiology procedures, high demand for minimally invasive surgeries, and complication of orthopedic surgeries with traditional equipment are key factors that are anticipated to propel the surgical imaging arms market during the forecast period.

Sleep Aids Market: The sleep aids devices consists of sleep laboratories, sleep apnea devices, medications and other things. Restless legs, narcolepsy, insomnia, and insomnia are some sleep disorders that disrupt quality of the sleep thereby boosting the global sleep aid devices market during forecast tenure.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Follow Us: Twitter | LinkedIn

Blog: https://tmrblog.com

Browse PR - https://www.transparencymarketresearch.com/pressrelease/triclabendazole-market.htm

View original content:https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html

SOURCE Transparency Market Research